Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 3
2009 2
2010 1
2011 1
2012 2
2013 1
2014 1
2015 2
2016 3
2017 2
2018 7
2019 4
2020 2
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action.
Luque-Navarro PM, Carrasco-Jiménez MP, Goracci L, Paredes JM, Espinar-Barranco L, Valverde-Pozo J, Torretta A, Parisini E, Mariotto E, Marchioro C, Laso A, Marco C, Viola G, Lanari D, López Cara LC. Luque-Navarro PM, et al. Eur J Med Chem. 2023 Jan 15;246:115003. doi: 10.1016/j.ejmech.2022.115003. Epub 2022 Dec 5. Eur J Med Chem. 2023. PMID: 36493617
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors.
Luque-Navarro PM, Mariotto E, Ballarotto M, Rubbini G, Aguilar-Troyano FJ, Fasiolo A, Torretta A, Parisini E, Macchiarulo A, Laso A, Marco C, Viola G, Carrasco-Jimenez MP, López-Cara LC. Luque-Navarro PM, et al. Pharmaceutics. 2022 Mar 27;14(4):715. doi: 10.3390/pharmaceutics14040715. Pharmaceutics. 2022. PMID: 35456549 Free PMC article.
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P, Sola-Leyva A, Luque-Navarro PM, Laso A, Ríos-Marco P, Ríos A, Lanari D, Torretta A, Parisini E, López-Cara LC, Marco C, Carrasco-Jiménez MP. García-Molina P, et al. Among authors: lopez cara lc. Pharmaceutics. 2022 Feb 16;14(2):426. doi: 10.3390/pharmaceutics14020426. Pharmaceutics. 2022. PMID: 35214160 Free PMC article.
Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism.
Serrán-Aguilera L, Mariotto E, Rubbini G, Castro Navas FF, Marco C, Carrasco-Jiménez MP, Ballarotto M, Macchiarulo A, Hurtado-Guerrero R, Viola G, Lopez-Cara LC. Serrán-Aguilera L, et al. Eur J Med Chem. 2020 Dec 1;207:112797. doi: 10.1016/j.ejmech.2020.112797. Epub 2020 Sep 6. Eur J Med Chem. 2020. PMID: 32977218
Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy.
Jabalera Y, Sola-Leyva A, Peigneux A, Vurro F, Iglesias GR, Vilchez-Garcia J, Pérez-Prieto I, Aguilar-Troyano FJ, López-Cara LC, Carrasco-Jiménez MP, Jimenez-Lopez C. Jabalera Y, et al. Among authors: lopez cara lc. Pharmaceutics. 2019 Aug 12;11(8):408. doi: 10.3390/pharmaceutics11080408. Pharmaceutics. 2019. PMID: 31408964 Free PMC article.
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors.
Romagnoli R, Prencipe F, Oliva P, Baraldi S, Baraldi PG, Schiaffino Ortega S, Chayah M, Kimatrai Salvador M, Lopez-Cara LC, Brancale A, Ferla S, Hamel E, Ronca R, Bortolozzi R, Mariotto E, Mattiuzzo E, Viola G. Romagnoli R, et al. J Med Chem. 2019 Feb 14;62(3):1274-1290. doi: 10.1021/acs.jmedchem.8b01391. Epub 2019 Jan 18. J Med Chem. 2019. PMID: 30633509
34 results